MOHAP Cardiology Exam MCQs

Exam Parameter

Details

Exam Title

MOHAP Cardiology Specialist / Consultant Exam

Authority

Ministry of Health and Prevention, UAE (MOHAP)

Delivery Mode

Prometric Computer-Based Test (CBT)

Exam Code

CAR-MOH / MOHAP-CARD

Question Format

Multiple-Choice (Single Best Answer)

Number of MCQs

100 to 150 questions

Exam Duration

2.5 to 3 hours (150 to 180 minutes)

Passing Score

65% for Specialist; 70% for Consultant

Negative Marking

None

Language

English

Score Result

Pass / Fail outcome posted to the MOHAP portal within a few business days

Score Validity

5 years

Specialty Module

Core Topics

Key Focus Areas & Clinical Scenarios

Coronary Artery Disease & Acute Coronary Syndromes

STEMI, NSTEMI, unstable angina, cardiogenic shock, mechanical complications of MI (free wall rupture, VSD, papillary muscle rupture), and antiplatelet therapy.

Deciding between primary PCI vs. pharmaco-invasive fibrinolytic therapy when transfer delays occur, picking dual antiplatelet therapy (DAPT) duration in high bleeding risk patients, recognizing early post-infarct murmurs, and stabilizing cardiogenic shock with inotropes and mechanical circulatory support.

Heart Failure & Cardiomyopathies

HFrEF, HFpEF, acute decompensated heart failure, dilated cardiomyopathy, hypertrophic obstructive cardiomyopathy (HOCM), restrictive cardiomyopathy, and cardiac amyloidosis.

Titrating four-pillar guideline-directed medical therapy (ARNI, beta-blocker, MRA, SGLT2i) in patients with borderline blood pressure and renal function, managing refractory volume overload with loop/thiazide combinations, evaluating outflow gradients in HOCM, and implantable cardioverter-defibrillator (ICD) criteria.

Arrhythmias & Electrophysiology

Atrial fibrillation, atrial flutter, supraventricular tachycardias (AVNRT, AVRT, WPW syndrome), monomorphic/polymorphic VT, long QT syndromes, and bradyarrhythmias.

Balancing stroke prevention with CHA2DS2-VASc against bleeding risk (HAS-BLED) when prescribing DOACs, distinguishing wide-complex tachycardias using Brugada/Vereckei algorithms, emergency cardioversion protocols, and pacing indications for high-grade AV block.

Valvular Heart Disease

Aortic stenosis, aortic regurgitation, mitral regurgitation (primary vs. secondary), mitral stenosis, tricuspid regurgitation, and prosthetic valve management.

Calculating aortic valve area and mean gradients in low-flow low-gradient aortic stenosis, choosing between surgical AVR and TAVI based on surgical risk scores, timing intervention for asymptomatic severe mitral regurgitation, and managing prosthetic valve thrombosis.

Pericardial & Myocardial Diseases

Acute pericarditis, cardiac tamponade, constrictive pericarditis, acute viral/autoimmune myocarditis, and stress-induced (Takotsubo) cardiomyopathy.

Spotting low-voltage QRS and electrical alternans on ECG, emergency bedside pericardiocentesis for Beck's triad, differentiating constrictive pericarditis from restrictive cardiomyopathy on echo/cath, and prescribing colchicine/NSAIDs for acute flares.

Infective Endocarditis & Aortic Emergencies

Modified Duke criteria, native vs. prosthetic valve endocarditis, blood culture sampling protocols, acute aortic dissection (Stanford Type A vs. B), and thoracic aortic aneurysms.

Selecting empiric IV bactericidal regimens while waiting for blood cultures, knowing the urgent surgical indications in endocarditis (refractory heart failure, large mobile vegetations), and aggressive heart rate/BP control using IV beta-blockers in acute Type B aortic dissection.

Congenital Heart Disease in Adults (ACHD)

Atrial septal defects (ostium secundum vs. primum), ventricular septal defects, patent ductus arteriosus, coarctation of the aorta, and repaired Tetralogy of Fallot.

Detecting early pulmonary hypertension and Eisenmenger physiology, deciding on percutaneous ASD closure based on Qp:Qs ratios and right heart volume overload, and monitoring late arrhythmias or pulmonary regurgitation in adult Fallot repairs.

Pulmonary Hypertension & Vascular Disease

Pulmonary arterial hypertension (WHO Groups 1–5), acute massive/submassive pulmonary embolism, deep vein thrombosis, and peripheral artery disease (PAD).

Interpreting right heart catheterization hemodynamics (mPAP, PCWP, PVR), selecting targeted pulmonary vasodilators (endothelin antagonists, PDE-5 inhibitors), thrombolysis criteria in hemodynamically unstable PE, and ankle-brachial index (ABI) interpretation in PAD.

Hypertension, Dyslipidemia & Prevention

Resistant hypertension, secondary hypertension workups (renal artery stenosis, primary aldosteronism, pheochromocytoma), familial hypercholesterolemia, and statin intolerance.

Managing multi-drug resistant blood pressure regimens including spironolactone, interpreting aldosterone-to-renin ratios, selecting PCSK9 inhibitors or ezetimibe for persistent high LDL, and stratified cardiovascular risk profiling.

Cardiovascular Imaging & Diagnostic Modalities

Transthoracic (TTE) and transesophageal (TEE) echocardiography, coronary CT angiography (CCTA), cardiac MRI (viability, late gadolinium enhancement), and nuclear perfusion SPECT/PET.

Assessing regional wall motion abnormalities, quantifying left ventricular ejection fraction and strain, interpreting ischemic vs. non-ischemic late gadolinium enhancement patterns on cardiac MRI, and evaluating reversible ischemia on stress imaging.

Critical Care, Patient Safety & Ethics

Cardiac arrest algorithms (ACLS), arterial line and central line complications, perioperative cardiac clearance for non-cardiac surgery, informed consent, and UAE health regulations.

Managing cardiac arrest with refractory VF/pVT, assessing perioperative MI risk using the Revised Cardiac Risk Index (RCRI), handling DNR documentation and end-of-life decisions with family members, and adhering to MOHAP practice guidelines.